One hundred Pfizer ($PFE) jobs once tapped for chopping are now safe, and the company's off-patent meds, like Lipitor, are the saviors. Patent expirations drove the pharma giant to announce cuts at its Ringaskiddy, Ireland, facility in 2012. But now, an unpredicted increase in manufacturing volumes of off-patent drugs will forestall most of the layoffs. More